Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/4166

TDMS Study 93023-07 Pathology Tables

NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01
Route: GAVAGE                                                                                                     Time: 11:07:14

                                                         FINAL #1/MICE




       Facility:  Southern Research Institute

       Chemical CAS #:  142-83-6

       Lock Date:  02/24/00

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      6            4            5            6                                     
    Moribund Sacrifice                                 2            8            8            4                                     
    Dosing Accident                                                                           1                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                42           37           37           37                                     
    Natural Death                                                                             2                                     
  Missing                                                           1                                                               
                                                                                                                                    
  Animals Examined Microscopically                    50           49           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (49)         (49)         (50)         (50)                                   
      Perforation                                                                             1 (2%)                                
      Epithelium, Hyperplasia, Squamous                1 (2%)                                                                       
      Periesophageal Tissue, Foreign Body                                                     1 (2%)                                
   Gallbladder                                        (44)         (45)         (47)         (41)                                   
      Cyst                                                          3 (7%)       1 (2%)       2 (5%)                                
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
   Liver                                              (50)         (49)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)       2 (4%)                                             
      Basophilic Focus                                              2 (4%)                                                          
      Congestion, Focal                                             1 (2%)       1 (2%)       1 (2%)                                
      Fibrosis, Focal                                  1 (2%)                                                                       
      Hemorrhage, Focal                                                          1 (2%)       1 (2%)                                
      Hyperplasia, Focal, Lymphoid                     1 (2%)       1 (2%)                                                          
      Hyperplasia, Lymphoid                            2 (4%)                    1 (2%)                                             
      Infarct, Chronic                                                           1 (2%)                                             
      Infiltration Cellular, Mixed Cell               41 (82%)     35 (71%)     36 (72%)     31 (62%)                               
      Mineralization, Focal                                                      1 (2%)                                             
      Mixed Cell Focus                                                           2 (4%)                                             
      Mixed Cell Focus, Multiple                       1 (2%)                                                                       
      Tension Lipidosis                                                          1 (2%)                                             
      Bile Duct, Cyst                                  1 (2%)                                 1 (2%)                                
      Bile Duct, Hyperplasia                           1 (2%)                                 1 (2%)                                
      Bile Duct, Hyperplasia, Cystic                   1 (2%)                                                                       
      Hepatocyte, Basophilic Focus                     1 (2%)       2 (4%)                    1 (2%)                                
      Hepatocyte, Cytomegaly                                        1 (2%)                                                          
      Hepatocyte, Depletion Glycogen, Diffuse          2 (4%)       1 (2%)       2 (4%)       1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatocyte, Eosinophilic Focus                                1 (2%)                    1 (2%)                                
      Hepatocyte, Karyomegaly                                       1 (2%)                                                          
      Hepatocyte, Mixed Cell Focus                                  1 (2%)       1 (2%)       1 (2%)                                
      Hepatocyte, Necrosis, Focal                      1 (2%)       3 (6%)                    2 (4%)                                
      Hepatocyte, Vacuolization Cytoplasmic,                                                                                        
          Diffuse                                      5 (10%)      2 (4%)       2 (4%)       5 (10%)                               
      Hepatocyte, Vacuolization Cytoplasmic, Focal     2 (4%)       1 (2%)                                                          
      Hepatocyte, Periportal, Depletion Glycogen                                 1 (2%)                                             
      Hepatocyte, Periportal, Vacuolization                                                                                         
          Cytoplasmic                                  8 (16%)      5 (10%)      3 (6%)       1 (2%)                                
      Hepatocyte, Centrilobular, Necrosis              1 (2%)                                 2 (4%)                                
      Hepatocyte, Centrilobular, Vacuolization                                                                                      
          Cytoplasmic                                                            2 (4%)       1 (2%)                                
      Hepatocyte, Midzonal, Vacuolization                                                                                           
          Cytoplasmic                                 12 (24%)      7 (14%)      3 (6%)       6 (12%)                               
      Oval Cell, Hyperplasia                           1 (2%)                                                                       
      Portal, Infiltration Cellular, Focal,                                                                                         
          Lymphocyte                                   1 (2%)                                                                       
      Serosa, Hyperplasia, Focal, Lymphoid                          1 (2%)                                                          
   Mesentery                                          (31)         (30)         (37)         (25)                                   
      Angiectasis                                      1 (3%)       2 (7%)                                                          
      Angiectasis, Focal                               1 (3%)                                 1 (4%)                                
      Congestion, Focal                                             1 (3%)                                                          
      Fibrosis, Focal                                               1 (3%)                                                          
      Hemorrhage                                                    1 (3%)       1 (3%)                                             
      Inflammation, Chronic                                                      1 (3%)                                             
      Artery, Mineralization                           2 (6%)                                                                       
      Fat, Necrosis                                   29 (94%)     28 (93%)     34 (92%)     22 (88%)                               
      Lymphatic, Angiectasis                                        1 (3%)       3 (8%)                                             
   Pancreas                                           (47)         (46)         (50)         (47)                                   
      Infiltration Cellular, Focal, Mixed Cell         1 (2%)                                                                       
      Necrosis, Focal                                                            1 (2%)                                             
      Acinus, Atrophy, Focal                                        1 (2%)                    1 (2%)                                
      Duct, Cyst                                       1 (2%)                    1 (2%)                                             
   Salivary Glands                                    (49)         (48)         (48)         (50)                                   
      Hyperplasia, Lymphoid                                                      2 (4%)                                             
      Submandibular Gland, Vacuolization                                                                                            
          Cytoplasmic                                               1 (2%)                                                          
   Stomach, Forestomach                               (48)         (48)         (50)         (48)                                   
      Diverticulum                                                                            1 (2%)                                
      Erosion                                                       1 (2%)       1 (2%)                                             
      Erosion, Focal                                                             1 (2%)                                             
      Inflammation, Focal                                           2 (4%)                    2 (4%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Ulcer                                            1 (2%)       1 (2%)       2 (4%)                                             
      Epithelium, Hyperplasia, Squamous                4 (8%)       8 (17%)     12 (24%)     31 (65%)                               
      Epithelium, Ulcer, Focal                                                                1 (2%)                                
   Stomach, Glandular                                 (45)         (45)         (48)         (46)                                   
      Glands, Degeneration, Cystic, Focal              1 (2%)                                 1 (2%)                                
      Muscularis, Mineralization                       1 (2%)                                                                       
   Tooth                                              (1)                                    (2)                                    
      Peridontal Tissue, Inflammation, Chronic                                                2 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (2)                       (1)                                                 
      Aorta, Mineralization                            2 (100%)                                                                     
      Pulmonary Artery, Mineralization                 2 (100%)                                                                     
      Pulmonary Vein, Mineralization                   2 (100%)                                                                     
   Heart                                              (49)         (49)         (50)         (50)                                   
      Infiltration Cellular, Mixed Cell                             1 (2%)                                                          
      Mineralization, Focal                            2 (4%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (48)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                             2 (4%)       2 (4%)       3 (6%)                                
      Angiectasis                                      1 (2%)       1 (2%)                                                          
      Cyst                                             2 (4%)                                                                       
      Cytoplasmic Alteration, Focal                    1 (2%)                                                                       
      Degeneration, Cystic, Focal                                   1 (2%)                                                          
      Infiltration Cellular, Mixed Cell                                                       1 (2%)                                
      Subcapsular, Hyperplasia, Focal                                            1 (2%)                                             
   Adrenal Medulla                                    (50)         (48)         (49)         (49)                                   
      Hyperplasia                                                   1 (2%)                                                          
   Parathyroid Gland                                  (45)         (46)         (49)         (47)                                   
      Cyst                                             1 (2%)       1 (2%)                    2 (4%)                                
      Cyst, Multiple                                                             1 (2%)                                             
      Hyperplasia, Cystic                                           1 (2%)                                                          
   Pituitary Gland                                    (46)         (48)         (47)         (50)                                   
      Angiectasis                                      3 (7%)       1 (2%)                    1 (2%)                                
      Pars Distalis, Angiectasis                                                              1 (2%)                                
      Pars Distalis, Cyst, Multiple                    1 (2%)                                                                       
      Pars Distalis, Cytoplasmic Alteration, Focal     6 (13%)      3 (6%)       2 (4%)       4 (8%)                                
      Pars Distalis, Degeneration, Cystic, Focal       2 (4%)       2 (4%)       4 (9%)       1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Hemorrhage, Focal                              3 (6%)                    1 (2%)                                
      Pars Distalis, Hyperplasia                                                 1 (2%)                                             
      Pars Distalis, Hyperplasia, Focal                2 (4%)       5 (10%)      6 (13%)      2 (4%)                                
      Rathke's Cleft, Hyperplasia, Cystic                                                     1 (2%)                                
   Thyroid Gland                                      (49)         (46)         (49)         (50)                                   
      Atrophy, Focal                                                             1 (2%)                                             
      Degeneration, Cystic, Focal                      7 (14%)     14 (30%)      9 (18%)     11 (22%)                               
      Ectopic Thymus                                                             2 (4%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Inflammation, Chronic, Focal                                               1 (2%)                                             
      Follicle, Cyst                                   1 (2%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (1)          (1)          (2)          (1)                                    
      Abdominal, Abscess                                            1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (47)         (45)         (45)         (50)                                   
      Angiectasis                                      1 (2%)                                                                       
      Degeneration, Cystic                                          2 (4%)       2 (4%)       1 (2%)                                
      Inflammation, Chronic                                                      1 (2%)                                             
   Ovary                                              (49)         (47)         (48)         (48)                                   
      Angiectasis                                                   1 (2%)       1 (2%)       1 (2%)                                
      Cyst                                            13 (27%)     11 (23%)     11 (23%)     10 (21%)                               
      Cyst, Multiple                                   1 (2%)                    1 (2%)                                             
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia, Cystic                              1 (2%)                                                                       
      Hyperplasia, Tubular                             1 (2%)                                                                       
      Inflammation, Suppurative                                                               1 (2%)                                
      Thrombosis                                                    1 (2%)       1 (2%)                                             
      Bilateral, Cyst                                  1 (2%)                                 1 (2%)                                
      Bilateral, Follicle, Cyst                                                               1 (2%)                                
      Bilateral, Follicle, Hemorrhage                                                         1 (2%)                                
      Periovarian Tissue, Mineralization                                                      1 (2%)                                
   Uterus                                             (50)         (49)         (50)         (50)                                   
      Angiectasis                                      1 (2%)                    1 (2%)       2 (4%)                                
      Congestion                                                    1 (2%)                                                          
      Cyst                                             1 (2%)       2 (4%)       1 (2%)                                             
      Cyst, Multiple                                                1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Edema                                            1 (2%)                                                                       
      Hemorrhage                                                    1 (2%)                                                          
      Hydrometra                                      33 (66%)     35 (71%)     40 (80%)     39 (78%)                               
      Inflammation, Chronic                                                                   1 (2%)                                
      Endometrium, Hyperplasia, Cystic                39 (78%)     39 (80%)     42 (84%)     40 (80%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (47)         (50)         (48)                                   
      Hyperplasia, Megakaryocyte                                                 1 (2%)                                             
      Myeloid Cell, Hyperplasia                        3 (6%)       5 (11%)      4 (8%)       5 (10%)                               
   Lymph Node                                         (8)          (9)          (9)          (7)                                    
      Iliac, Hyperplasia, Plasma Cell                  1 (13%)      1 (11%)                   1 (14%)                               
      Iliac, Pigmentation                              1 (13%)                                                                      
      Inguinal, Hyperplasia, Lymphoid                  1 (13%)                   2 (22%)                                            
      Inguinal, Hyperplasia, Plasma Cell               1 (13%)      1 (11%)                                                         
      Inguinal, Infiltration Cellular, Mixed Cell                                             1 (14%)                               
      Mediastinal, Hemorrhage                                                                 1 (14%)                               
      Mediastinal, Hyperplasia, Lymphoid               1 (13%)      2 (22%)      2 (22%)                                            
      Mediastinal, Hyperplasia, Plasma Cell            1 (13%)                                1 (14%)                               
      Renal, Hyperplasia, Plasma Cell                                                         1 (14%)                               
      Renal, Infiltration Cellular, Mixed Cell                                                1 (14%)                               
   Lymph Node, Mandibular                             (47)         (47)         (48)         (49)                                   
      Congestion                                                                 1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Hyperplasia, Plasma Cell                         1 (2%)                                                                       
   Lymph Node, Mesenteric                             (47)         (46)         (49)         (49)                                   
      Angiectasis                                                   2 (4%)                                                          
      Atypia Cellular                                               1 (2%)                                                          
      Hyperplasia, Cystic                                                                     1 (2%)                                
      Hyperplasia, Histiocytic                                      1 (2%)       2 (4%)                                             
      Hyperplasia, Lymphoid                                         1 (2%)       2 (4%)                                             
      Hyperplasia, Plasma Cell                         3 (6%)       2 (4%)                                                          
   Spleen                                             (48)         (47)         (50)         (49)                                   
      Accessory Spleen                                              1 (2%)                                                          
      Angiectasis                                                   1 (2%)                    1 (2%)                                
      Congestion                                       1 (2%)       3 (6%)                    2 (4%)                                
      Depletion Cellular                                                         2 (4%)                                             
      Hematopoietic Cell Proliferation                20 (42%)     29 (62%)     29 (58%)     17 (35%)                               
      Hemorrhage                                       1 (2%)       1 (2%)                    1 (2%)                                
      Hyperplasia, Histiocytic                         1 (2%)                                                                       
      Hyperplasia, Lymphoid                            8 (17%)      9 (19%)      7 (14%)      7 (14%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Necrosis, Focal                                  1 (2%)       2 (4%)                                                          
      Pigmentation, Focal                                                        1 (2%)                                             
      Thrombosis                                                                              1 (2%)                                
   Thymus                                             (44)         (46)         (48)         (46)                                   
      Atrophy                                                                    1 (2%)                                             
      Cyst                                                                       1 (2%)       3 (7%)                                
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (48)         (49)         (50)         (50)                                   
      Ectasia                                          2 (4%)       1 (2%)       2 (4%)       1 (2%)                                
      Hyperplasia                                      2 (4%)                    3 (6%)                                             
      Metaplasia, Focal, Squamous                                   1 (2%)                                                          
   Skin                                               (50)         (49)         (50)         (50)                                   
      Ulcer                                            1 (2%)                                                                       
      Hair Follicle, Atrophy, Focal                    1 (2%)                                                                       
      Subcutaneous Tissue, Fibrosis, Focal             1 (2%)                                                                       
      Subcutaneous Tissue, Hemorrhage, Focal                        1 (2%)                    1 (2%)                                
      Subcutaneous Tissue, Infiltration Cellular,                                                                                   
           Focal, Mixed Cell                                        1 (2%)                                                          
      Subcutaneous Tissue, Inflammation, Chronic                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                    (6)          (4)          (5)          (2)                                    
      Fibrosis                                                                   1 (20%)                                            
      Inflammation, Chronic                            1 (17%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (48)         (50)         (50)                                   
      Compression, Focal                               2 (4%)       3 (6%)       2 (4%)       1 (2%)                                
      Hemorrhage, Focal                                                          1 (2%)       1 (2%)                                
      Ventricle, Hydrocephalus                         1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
   Lung                                               (49)         (49)         (50)         (50)                                   
      Congestion                                       1 (2%)       2 (4%)       2 (4%)       2 (4%)                                
      Fibrosis, Focal                                  1 (2%)                                                                       
      Hemorrhage                                       1 (2%)       2 (4%)       2 (4%)                                             
      Hemorrhage, Focal                                                                       1 (2%)                                
      Hyperplasia, Histiocytic                         2 (4%)                    1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)       3 (6%)       2 (4%)                                             
      Infiltration Cellular, Focal, Mixed Cell                                                1 (2%)                                
      Infiltration Cellular, Mixed Cell                             1 (2%)                                                          
      Inflammation, Suppurative                                                               1 (2%)                                
      Thrombosis                                       1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                                                        1 (2%)                                
      Artery, Mineralization                           1 (2%)                                                                       
      Vein, Mineralization                             1 (2%)                                                                       
   Nose                                               (50)         (48)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
      Inflammation, Suppurative                       18 (36%)     22 (46%)     23 (46%)     16 (32%)                               
      Mucosa, Glands, Dilatation, Focal                5 (10%)                   2 (4%)       6 (12%)                               
      Nasolacrimal Duct, Cyst                                                    1 (2%)                                             
      Nasolacrimal Duct, Inflammation                  1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Nasolacrimal Duct, Mineralization                1 (2%)                                                                       
      Olfactory Epithelium, Cytoplasmic Alteration    28 (56%)     23 (48%)     34 (68%)     28 (56%)                               
      Respiratory Epithelium, Cytoplasmic                                                                                           
          Alteration                                  50 (100%)    47 (98%)     49 (98%)     48 (96%)                               
      Respiratory Epithelium, Necrosis                              1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)          (3)          (2)          (2)                                    
      Atrophy                                                       2 (67%)      2 (100%)                                           
      Cornea, Hyperplasia, Focal, Squamous             1 (50%)      1 (33%)                                                         
      Cornea, Inflammation, Focal                      1 (50%)      1 (33%)                                                         
   Harderian Gland                                    (8)          (6)          (4)          (1)                                    
      Hyperplasia, Focal                               1 (13%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (47)         (49)         (48)                                   
      Atrophy                                                                                 1 (2%)                                
      Congestion                                                    1 (2%)       1 (2%)                                             
      Cyst                                             3 (6%)       4 (9%)       1 (2%)       1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Cyst, Multiple                                                             1 (2%)                                             
      Hydronephrosis                                                                          1 (2%)                                
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Infarct                                          3 (6%)       1 (2%)       5 (10%)      4 (8%)                                
      Infarct, Focal                                   1 (2%)                                                                       
      Inflammation, Chronic, Focal                                  1 (2%)                                                          
      Metaplasia, Focal, Osseous                       2 (4%)       1 (2%)                    1 (2%)                                
      Nephropathy                                     19 (38%)     15 (32%)     17 (35%)     22 (46%)                               
      Artery, Mineralization                           2 (4%)                                                                       
      Papilla, Mineralization, Focal                                             1 (2%)                                             
      Papilla, Necrosis                                                          4 (8%)       1 (2%)                                
      Renal Tubule, Accumulation, Hyaline Droplet      3 (6%)                    2 (4%)       1 (2%)                                
      Renal Tubule, Accumulation, Hyaline Droplet,                                                                                  
           Focal                                                                              1 (2%)                                
      Renal Tubule, Necrosis                                                     1 (2%)                                             
      Renal Tubule, Pigmentation                                    1 (2%)                    2 (4%)                                
   Urinary Bladder                                    (48)         (47)         (48)         (48)                                   
      Transitional Epithelium, Hyperplasia             1 (2%)                                                                       
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 3            3            3            8                                     
    Natural Death                                      3            8            3            3                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                44           39           44           38                                     
    Natural Death                                                                             1                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (48)         (47)         (45)         (46)                                   
      Cyst                                             2 (4%)                    2 (4%)       1 (2%)                                
      Cyst, Multiple                                   1 (2%)                    1 (2%)                                             
      Infiltration Cellular, Polymorphonuclear                      1 (2%)                                                          
      Epithelium, Degeneration, Hyaline                             1 (2%)       2 (4%)                                             
      Epithelium, Hyperplasia, Adenomatous                          1 (2%)       1 (2%)                                             
   Intestine Large, Cecum                             (47)         (45)         (48)         (48)                                   
      Serosa, Fibrosis, Focal                          1 (2%)                                                                       
   Intestine Small, Duodenum                          (47)         (47)         (48)         (49)                                   
      Epithelium, Cyst                                 1 (2%)                                                                       
   Intestine Small, Jejunum                           (47)         (45)         (49)         (48)                                   
      Inflammation, Chronic Active                                                            1 (2%)                                
      Peyer's Patch, Hyperplasia, Histiocytic                       1 (2%)                                                          
      Peyer's Patch, Hyperplasia, Lymphoid                                       1 (2%)                                             
   Intestine Small, Ileum                             (47)         (45)         (47)         (48)                                   
      Infiltration Cellular, Mixed Cell                                          1 (2%)                                             
      Serosa, Fibrosis, Focal                          1 (2%)                                                                       
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      2 (4%)                                                                       
      Angiectasis, Focal                                            1 (2%)                                                          
      Clear Cell Focus                                                                        1 (2%)                                
      Congestion                                       1 (2%)                                                                       
      Congestion, Focal                                1 (2%)       3 (6%)       1 (2%)       3 (6%)                                
      Eosinophilic Focus                                                                      1 (2%)                                
      Eosinophilic Focus, Multiple                                  1 (2%)                                                          
      Erythrophagocytosis                                                        1 (2%)                                             
      Hematopoietic Cell Proliferation                                                        1 (2%)                                
      Hemorrhage, Focal                                             2 (4%)       1 (2%)       2 (4%)                                
      Hyperplasia, Focal, Histiocytic                                            1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hyperplasia, Focal, Lymphoid                                               1 (2%)                                             
      Hyperplasia, Histiocytic                                      1 (2%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Infarct                                          2 (4%)                                                                       
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Infiltration Cellular, Mixed Cell               31 (62%)     27 (54%)     30 (60%)     31 (62%)                               
      Inflammation, Chronic                                                      1 (2%)       1 (2%)                                
      Mixed Cell Focus                                 1 (2%)       1 (2%)                    3 (6%)                                
      Necrosis, Focal                                               2 (4%)       1 (2%)                                             
      Pigmentation, Focal                                                        1 (2%)                                             
      Bile Duct, Hyperplasia                                                                  1 (2%)                                
      Hepatocyte, Basophilic Focus                                  2 (4%)       1 (2%)       1 (2%)                                
      Hepatocyte, Cytomegaly                           2 (4%)       2 (4%)                    2 (4%)                                
      Hepatocyte, Eosinophilic Focus                   3 (6%)       5 (10%)      2 (4%)       4 (8%)                                
      Hepatocyte, Eosinophilic Focus, Multiple                                   1 (2%)                                             
      Hepatocyte, Karyomegaly                          2 (4%)                                 2 (4%)                                
      Hepatocyte, Mixed Cell Focus                     1 (2%)       6 (12%)      9 (18%)      5 (10%)                               
      Hepatocyte, Mixed Cell Focus, Multiple           1 (2%)       3 (6%)                    3 (6%)                                
      Hepatocyte, Necrosis, Focal                      1 (2%)       1 (2%)       2 (4%)       2 (4%)                                
      Hepatocyte, Vacuolization Cytoplasmic,                                                                                        
          Diffuse                                      6 (12%)      1 (2%)       1 (2%)       4 (8%)                                
      Hepatocyte, Vacuolization Cytoplasmic, Focal    13 (26%)     15 (30%)     16 (32%)     12 (24%)                               
      Hepatocyte, Periportal, Vacuolization                                                                                         
          Cytoplasmic                                  3 (6%)       3 (6%)       2 (4%)       2 (4%)                                
      Hepatocyte, Centrilobular, Depletion Glycogen                 1 (2%)                                                          
      Hepatocyte, Centrilobular, Necrosis                           1 (2%)                                                          
      Hepatocyte, Midzonal, Vacuolization                                                                                           
          Cytoplasmic                                 17 (34%)      9 (18%)     20 (40%)     10 (20%)                               
      Oval Cell, Hyperplasia                                                     1 (2%)       1 (2%)                                
   Mesentery                                          (25)         (28)         (33)         (32)                                   
      Fibrosis, Focal                                  1 (4%)                    1 (3%)                                             
      Hemorrhage                                                    1 (4%)       1 (3%)       1 (3%)                                
      Hemorrhage, Focal                                1 (4%)                                                                       
      Inflammation, Chronic                            1 (4%)       4 (14%)                   2 (6%)                                
      Fat, Necrosis                                   24 (96%)     27 (96%)     32 (97%)     31 (97%)                               
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Necrosis, Focal                                               1 (2%)                    1 (2%)                                
      Acinus, Atrophy, Diffuse                                                                1 (2%)                                
      Acinus, Atrophy, Focal                           1 (2%)       1 (2%)                    1 (2%)                                
      Acinus, Cytoplasmic Alteration                                1 (2%)                                                          
      Duct, Cyst                                                                 1 (2%)       1 (2%)                                
      Duct, Inflammation, Chronic, Focal                                                      1 (2%)                                
   Stomach, Forestomach                               (50)         (50)         (48)         (50)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Focal                              3 (6%)       1 (2%)       3 (6%)       6 (12%)                               
      Ulcer                                            2 (4%)                    3 (6%)      10 (20%)                               
      Ulcer, Focal                                                                            1 (2%)                                
      Epithelium, Cyst                                                                        1 (2%)                                
      Epithelium, Hyperplasia, Squamous               14 (28%)      7 (14%)      9 (19%)     26 (52%)                               
   Stomach, Glandular                                 (50)         (48)         (48)         (50)                                   
      Erosion                                                                                 1 (2%)                                
      Hyperplasia                                                                             1 (2%)                                
      Mineralization                                   1 (2%)                                                                       
      Glands, Degeneration, Cystic, Focal                                                     3 (6%)                                
   Tooth                                              (19)         (21)         (16)         (19)                                   
      Malformation                                    11 (58%)     13 (62%)     10 (63%)     12 (63%)                               
      Peridontal Tissue, Inflammation, Chronic        10 (53%)      9 (43%)      8 (50%)     10 (53%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Mixed Cell                                                       2 (4%)                                
      Inflammation, Chronic, Focal                     1 (2%)                                 2 (4%)                                
      Mineralization, Focal                                         1 (2%)                                                          
      Valve, Hemorrhage, Focal                                                                1 (2%)                                
      Valve, Inflammation, Chronic, Focal                                                     1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)                    1 (2%)       5 (10%)                               
      Cytoplasmic Alteration, Focal                    7 (14%)      2 (4%)       3 (6%)       5 (10%)                               
      Hypertrophy, Focal                               1 (2%)                    1 (2%)                                             
      Bilateral, Accessory Adrenal Cortical Nodule                                            1 (2%)                                
      Subcapsular, Hyperplasia, Focal                 11 (22%)      7 (14%)      8 (16%)      7 (14%)                               
   Adrenal Medulla                                    (49)         (50)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Hyperplasia                                      1 (2%)                    1 (2%)       1 (2%)                                
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                   1 (2%)       1 (2%)       2 (4%)                                
   Parathyroid Gland                                  (47)         (48)         (49)         (46)                                   
      Cyst                                             1 (2%)                    2 (4%)       1 (2%)                                
   Pituitary Gland                                    (48)         (47)         (48)         (49)                                   
      Pars Distalis, Cyst                              3 (6%)       2 (4%)       3 (6%)       3 (6%)                                
      Pars Distalis, Cyst, Multiple                                              1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Cytoplasmic Alteration, Focal                                            1 (2%)                                
      Pars Distalis, Degeneration, Cystic, Focal                                 1 (2%)                                             
      Pars Distalis, Hyperplasia, Focal                             2 (4%)       1 (2%)                                             
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      Degeneration, Cystic, Focal                      7 (14%)      5 (10%)      5 (10%)      6 (12%)                               
      Follicle, Cyst                                   1 (2%)       1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Peritoneum                                                      (1)                                                              
      Inflammation, Focal                                           1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Coagulating Gland                                  (1)          (2)          (1)          (1)                                    
      Inflammation, Chronic                                                                   1 (100%)                              
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
      Inflammation, Chronic                            1 (2%)       1 (2%)                                                          
      Bilateral, Hemorrhage                            1 (2%)                                                                       
   Preputial Gland                                    (50)         (50)         (50)         (50)                                   
      Degeneration, Cystic                            16 (32%)     17 (34%)      9 (18%)     21 (42%)                               
      Inflammation, Chronic                            1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Metaplasia, Squamous                                                                    1 (2%)                                
   Prostate                                           (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic                            1 (2%)                                 1 (2%)                                
      Epithelium, Hyperplasia, Focal                                                          1 (2%)                                
   Seminal Vesicle                                    (50)         (50)         (50)         (50)                                   
      Dilatation                                       1 (2%)                    2 (4%)                                             
      Inflammation, Chronic                                         1 (2%)       2 (4%)       1 (2%)                                
      Bilateral, Dilatation                                                      1 (2%)                                             
   Testes                                             (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Mineralization                                                                          1 (2%)                                
      Interstitial Cell, Hyperplasia                   1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Fibrosis, Focal                                               1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   13                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Thrombosis, Chronic                                           1 (2%)                                                          
      Myeloid Cell, Hyperplasia                        1 (2%)       1 (2%)       2 (4%)       3 (6%)                                
   Lymph Node                                         (1)          (4)          (2)          (7)                                    
      Inguinal, Hyperplasia, Lymphoid                               1 (25%)                                                         
      Inguinal, Hyperplasia, Plasma Cell                                                      1 (14%)                               
      Mediastinal, Congestion                                       1 (25%)                                                         
      Mediastinal, Hyperplasia, Lymphoid               1 (100%)                                                                     
      Mediastinal, Hyperplasia, Plasma Cell                                      1 (50%)      3 (43%)                               
      Mediastinal, Infiltration Cellular, Mixed                                                                                     
          Cell                                                                                1 (14%)                               
   Lymph Node, Mandibular                             (48)         (48)         (49)         (49)                                   
      Hyperplasia, Histiocytic                         1 (2%)                                                                       
      Hyperplasia, Lymphoid                            1 (2%)       3 (6%)       1 (2%)       1 (2%)                                
      Hyperplasia, Plasma Cell                         2 (4%)       1 (2%)       1 (2%)       3 (6%)                                
      Pigmentation                                                               1 (2%)                                             
   Lymph Node, Mesenteric                             (50)         (49)         (47)         (50)                                   
      Congestion                                                                              1 (2%)                                
      Hemorrhage                                       1 (2%)                    2 (4%)                                             
      Hyperplasia, Histiocytic                                      1 (2%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Hyperplasia, Plasma Cell                         6 (12%)                   2 (4%)       2 (4%)                                
      Infiltration Cellular, Polymorphonuclear         1 (2%)                                                                       
   Spleen                                             (49)         (50)         (50)         (49)                                   
      Depletion Cellular                                            1 (2%)                    1 (2%)                                
      Hematopoietic Cell Proliferation                14 (29%)     18 (36%)     18 (36%)     23 (47%)                               
      Hyperplasia, Histiocytic                                      1 (2%)                                                          
      Hyperplasia, Lymphoid                            3 (6%)       3 (6%)       2 (4%)                                             
   Thymus                                             (44)         (46)         (47)         (42)                                   
      Angiectasis                                      1 (2%)       1 (2%)                                                          
      Atrophy                                          1 (2%)       1 (2%)       1 (2%)                                             
      Cyst                                            10 (23%)      9 (20%)      5 (11%)      9 (21%)                               
      Cyst, Multiple                                                             2 (4%)                                             
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (50)                                   
      Hyperkeratosis, Focal                                                                   1 (2%)                                
      Inflammation, Chronic, Focal                                               1 (2%)       1 (2%)                                
      Ulcer                                                                      2 (4%)                                             
      Epidermis, Hyperplasia, Focal                                                           1 (2%)                                
      Subcutaneous Tissue, Congestion, Focal           1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   14                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Subcutaneous Tissue, Necrosis, Fatty, Focal                                1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Cranium, Hyperostosis                            1 (2%)                                                                       
   Skeletal Muscle                                    (1)                       (2)          (3)                                    
      Infiltration Cellular, Focal, Lipocyte           1 (100%)                  1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Compression, Focal                                            1 (2%)                                                          
      Hemorrhage, Focal                                                          1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                       1 (2%)                    3 (6%)       1 (2%)                                
      Hemorrhage                                                    1 (2%)       2 (4%)       1 (2%)                                
      Hyperplasia, Histiocytic                         5 (10%)      3 (6%)       6 (12%)      6 (12%)                               
      Hyperplasia, Lymphoid                                         2 (4%)       2 (4%)       1 (2%)                                
      Infiltration Cellular, Eosinophil, Focal                                                1 (2%)                                
      Infiltration Cellular, Focal, Mixed Cell                      1 (2%)                                                          
      Infiltration Cellular, Mixed Cell                             2 (4%)       2 (4%)       1 (2%)                                
      Inflammation, Chronic, Focal                                  1 (2%)                                                          
      Metaplasia, Focal, Osseous                                    1 (2%)                                                          
      Pigmentation, Focal                                           1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia                 5 (10%)      6 (12%)      4 (8%)                                             
      Alveolar Epithelium, Hyperplasia, Focal                                                 1 (2%)                                
      Mediastinum, Necrosis, Fatty, Focal                           1 (2%)                                                          
   Nose                                               (50)         (50)         (48)         (50)                                   
      Foreign Body                                                  1 (2%)                                                          
      Inflammation, Suppurative                        7 (14%)     11 (22%)     13 (27%)     13 (26%)                               
      Mineralization, Focal                                                                   1 (2%)                                
      Polyp, Inflammatory                                                        2 (4%)                                             
      Glands, Cytoplasmic Alteration                   1 (2%)                                                                       
      Mucosa, Glands, Dilatation, Focal                4 (8%)       2 (4%)                    6 (12%)                               
      Nasolacrimal Duct, Inflammation                  2 (4%)       2 (4%)                    1 (2%)                                
      Olfactory Epithelium, Cytoplasmic Alteration    24 (48%)     19 (38%)     17 (35%)     19 (38%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   15                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Respiratory Epithelium, Cytoplasmic                                                                                           
          Alteration                                  48 (96%)     47 (94%)     45 (94%)     45 (90%)                               
      Respiratory Epithelium, Metaplasia, Squamous                               1 (2%)                                             
      Sinus, Glands, Fibrosis, Focal                                             1 (2%)                                             
      Vomeronasal Organ, Cyst                                       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (3)                       (3)                                    
      Atrophy                                                       1 (33%)                                                         
      Cornea, Hyperplasia, Focal, Squamous                          1 (33%)                   3 (100%)                              
      Cornea, Inflammation, Chronic                                 2 (67%)                                                         
      Cornea, Inflammation, Focal                                   1 (33%)                   3 (100%)                              
      Cornea, Necrosis, Focal                                                                 2 (67%)                               
      Iris, Synechia                                                1 (33%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (48)         (50)         (50)                                   
      Accumulation, Hyaline Droplet                                              1 (2%)                                             
      Atrophy                                                                    1 (2%)                                             
      Atrophy, Focal                                   1 (2%)       2 (4%)       1 (2%)                                             
      Congestion                                       2 (4%)       1 (2%)       1 (2%)                                             
      Cyst                                             7 (14%)     11 (23%)      4 (8%)       5 (10%)                               
      Cyst, Multiple                                                1 (2%)       1 (2%)       1 (2%)                                
      Hydronephrosis                                                             1 (2%)                                             
      Hyperplasia, Lymphoid                            1 (2%)                    1 (2%)                                             
      Infiltration Cellular, Focal, Mixed Cell                                                1 (2%)                                
      Inflammation, Suppurative                        1 (2%)                                 1 (2%)                                
      Metaplasia, Focal, Osseous                       3 (6%)       1 (2%)       1 (2%)                                             
      Nephropathy                                     47 (94%)     44 (92%)     48 (96%)     46 (92%)                               
      Papilla, Necrosis                                             1 (2%)                                                          
      Renal Tubule, Accumulation, Hyaline Droplet                                             1 (2%)                                
      Renal Tubule, Dilatation, Focal                  1 (2%)                                                                       
      Renal Tubule, Hyperplasia, Focal                 1 (2%)       2 (4%)       2 (4%)       4 (8%)                                
      Renal Tubule, Pigmentation                       1 (2%)       1 (2%)                                                          
   Urethra                                            (1)                       (1)                                                 
      Inflammation                                     1 (100%)                                                                     
      Necrosis, Focal                                  1 (100%)                                                                     
   Urinary Bladder                                    (50)         (49)         (49)         (50)                                   
      Inflammation, Suppurative                        1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   16                                                              
                                                                                                                                   
NTP Experiment-Test: 93023-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           2,4-HEXADIENAL                                      Date: 02/15/01    
Route: GAVAGE                                                                                                     Time: 11:07:14    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0            30           60           120                                       
                                                   MG/KG/DY     MG/KG/DY     MG/KG/DY     MG/KG/DY                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Transitional Epithelium, Hyperplasia                                                    1 (2%)                                
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   17                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------